Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$5.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 7 most recent Form 4 transactions.
| Latigo Biotherapeutics,… |
| CCONV |
| 177,978 |
| — |
| — |
| +36.0% |
| Open the original filing on SEC.gov |
| Aug 10 | LTGO | Latigo Biotherapeutics,… | CCONV | 494,800 | — | — | — | Open the original filing on SEC.gov |
| Aug 6 | ATTO | Attovia Therapeutics, Inc. | CCONV◆ | 782,855 | — | — | — | Open the original filing on SEC.gov |
| Aug 6 | ATTO | Attovia Therapeutics, Inc. | PBUY | 300,000 | $17.00 | $5.1M | +38.3% | Open the original filing on SEC.gov |
| Aug 6 | ATTO | Attovia Therapeutics, Inc. | CCONV | 782,855 | — | — | — | Open the original filing on SEC.gov |